Liquid Biopsy performance comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS testing published in Scientific Reports (Nature Journal)
Sysmex R&D Center Europe Launches Joint Research with Oxford University and JVCKENWOOD to Establish a Technique for Predicting the Onset of Preeclampsia using Exosomes
A welcome addition to our portfolio: Sentinel’s SENTiFOB® analyser with new cap-piercing function, ideal for low-middle throughput, for the detection of faecal occult blood using FOBGold® reagents
World Anti-Doping Agency Coordinates Global Implementation of Sysmex Analyzers at All Blood Laboratories
Sysmex Inostics OncoBEAM™-EGFR digital PCR liquid biopsy demonstrates two-fold higher detection of p.T790M mutations in 183 NSCLC patients in comparison study
Sysmex Inostics’ SafeSEQ ER+/HER2- breast cancer panel demonstrates equivalent sensitivity to OncoBEAM™ enhanced digital PCR technology for detection of mutations in circulating tumor DNA
Sysmex Europe GmbH was awarded as ‘Top Employer SME 2019’ and ranked 8th in the category ‘Electronics and Electrical Engineering, Medical Devices’
Promoting Business Process Restructuring through Digitalization to Reinforce Corporate Foundations and Create New Value
Sysmex Opens Technopark East Site, a Bio-Diagnostic Reagent Base
Sysmex Obtains CE Certification for Automated Hematology Analyzer XN-31, Which Has an Automatic Measurement Function for Red Blood Cells Infected by Malaria Parasites
Sysmex to Be Special Sponsor of the Kobe Marathon 2019
Search
Sysmex RDCE
Sysmex Europe
Company
Back
Research & Development
Back
Other Sites
Menu
